Celsion Corporation (NASDAQ: CLSN) is having an overwhelmingly strong day in the market today, and for good reason. The company released positive clinical data, causing excitement among investors and pushing the stock upward. Of course, our partners at Trade Ideas were the first to alert us to the gains. At the moment (9:24), CLSN is trading at $0.36 er share after a gain of $0.06 per share or 20.57% thus far today.
CLSN Releases Positive Clinical Data
As mentioned above, Celsion Corporation is having a strong time in the market today after releasing positive clinical data. The data surrounded ThermoDox(R) as a way to increase concentrations of Doxorubicin accumulation and distribution within the bladder wall. According to the release, the data shows that this is exactly what’s happening. In a statement, Dr. Bradford Wood, MD, Director at the NIH Center for Interventional Oncology and Chief of the NIH Clinical Center Intervention Radiology had the following to offer…
“The incomplete response of bladder tumors to intravesical drugs, like doxorubicin and mitomycin C, has been attributed in part to inadequate drug delivery and poor penetration across the urothelium resulting in sub-therapeutic drug concentrations in the bladder wall… To address this limitation, one promising strategy to enhance the permeability of the bladder wall to improve the efficacy of intravesical chemotherapy is the use of hyperthermia to stimulate the release of chemotherapeutic agents from thermosensitive nanocarriers for patients who have failed standard first line therapy for bladder cancer.”
Stop wasting your time! Find winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will be keeping a close eye on CLSN. In particular, we’re interested in following the continued work with regard to ThermoDox(R) as the data that was released today looks overwhelmingly promising. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Want The News Faster?
Check out the CNA Finance News Desk to get the scoop before we have the time to write the full story!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!
[Image Courtesy of Wikimedia]